Clinical trial
Co-Administration Of Fosamprenavir With Methadone: A Drug Interaction Study.
NCT00481182 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00481182 |
|---|---|
| Title | Co-Administration Of Fosamprenavir With Methadone: A Drug Interaction Study. |
| Official title | A Phase I, Open-Label, 2-Period, Single-Sequence, Drug Interaction Study to Assess Steady-State Plasma Methadone Enantiomer Pharmacokinetics Following Co-Administration of Methadone QD With Fosamprenavir 700mg BID + RTV 100mg BID in Opiate-Dependent, HIV Seronegative, Adult Subjects |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy Subjects |
| Intervention type | Drug |
| Interventions | fosamprenavir + ritonavir + methadone |
| Enrollment | 20 |
| Start date | Feb 1, 2005 |
| First posted | Jun 1, 2007 |
| Last update posted | Feb 23, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: